The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions
Open accessAbstract
In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key goals for improving outcomes including early detection, effective prognostic indicators of treatment response, and accurate identification of patients at high risk for recurrence. Although new therapeutic regimens developed over the past decade have increased survival, there is substantial room for improvement in selecting targeted treatment regimens for the patients who will derive the most benefit. Recently, there have been exciting developments in identifying high-risk patient cohorts, refinements in the understanding of systemic vs localized drug delivery to metastatic niches, liquid biomarker development, and dramatic advances in tumor immune therapy, all of which promise new and innovative approaches to tackling the problem of detecting and treating the metastatic spread of CRC to the liver. Our multidisciplinary group held a state-of-the-science symposium this past year to review advances in this rapidly evolving field. Herein, we present a discussion around the issues facing treatment of patients with CRC liver metastases, including the relationship of discrete gene signatures with prognosis. We also discuss the latest advances to maximize regional and systemic therapies aimed at decreasing intrahepatic recurrence, review recent insights into the tumor microenvironment, and summarize advances in noninvasive multimodal biomarkers for early detection of primary and recurrent disease. As we continue to advance clinically and technologically in the field of colorectal tumor biology, our goal should be continued refinement of predictive and prognostic studies to decrease recurrence after curative resection and minimize treatment toxicity to patients through a tailored multidisciplinary approach to cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Self-citationCirculating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,715
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
André, T., Boni, C., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Bonetti, A., Clingan, P., Bridgewater, J., Rivera, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6771 · Cited by 2,277
de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R. L., Bardelli, A., & Bernards, R. (2012) · Nature · doi:10.1038/nature10868 · Cited by 2,051
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G. J., Schlag, P. M., Rougier, P., Bechstein, W. O., Primrose, J. N., Walpole, E. T., Finch-Jones, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60455-9 · Cited by 1,937
APC mutations occur early during colorectal tumorigenesis
Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., & Kinzler, K. W. (1992) · Nature · doi:10.1038/359235a0 · Cited by 1,924
Van Cutsem, E., Köhne, C.-H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5091 · Cited by 1,882
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,841
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
(1977) · PubMed · Cited by 1,801
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
QUASAR Collaborative Group (2007) · The Lancet · doi:10.1016/s0140-6736(07)61866-2 · Cited by 1,437
Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G. J., Schlag, P. M., Rougier, P., Bechstein, W. O., Primrose, J. N., Walpole, E. T., Finch-Jones, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70447-9 · Cited by 1,306
Challenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300
Liver resection for colorectal metastases.
Fong, Y., Cohen, A. M., Fortner, J. G., Enker, W. E., Turnbull, A. D., Coit, D. G., Marrero, A. M., Prasad, M., Blumgart, L. H., & Brennan, M. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.938 · Cited by 1,284
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
Self-citationActual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
Tomlinson, J. S., Jarnagin, W. R., DeMatteo, R. P., Fong, Y., Kornprat, P., Gonen, M., Kemeny, N., Brennan, M. F., Blumgart, L. H., & D'Angelica, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0833 · Cited by 1,187
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Calon, A., Lonardo, E., Berenguer-Llergo, A., Espinet, E., Hernando-Momblona, X., Iglesias, M., Sevillano, M., Palomo-Ponce, S., Tauriello, D. V. F., Byrom, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3225 · Cited by 1,070
Mlecnik, B., Bindea, G., Angell, H. K., Maby, P., Angelova, M., Tougeron, D., Church, S. E., Lafontaine, L., Fischer, M., Fredriksen, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.025 · Cited by 1,034
Ruffell, B., Chang-Strachan, D., Chan, V., Rosenbusch, A., Ho, C. M. T., Pryer, N., Daniel, D., Hwang, E. S., Rugo, H. S., & Coussens, L. M. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.006 · Cited by 1,008
Self-citationThe Chromosomal Instability Pathway in Colon Cancer
Pino, M. S., & Chung, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.065 · Cited by 932
Palucka, A. K., & Coussens, L. M. (2016) · Cell · doi:10.1016/j.cell.2016.01.049 · Cited by 843
Self-citationCirculating Exosomal microRNAs as Biomarkers of Colon Cancer
Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092921 · Cited by 809
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
Stroun, M., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Beljanski, M. (2009) · Oncology · doi:10.1159/000226740 · Cited by 733
Tejpar, S., Stintzing, S., Ciardiello, F., Tabernero, J., Van Cutsem, E., Beier, F., Esser, R., Lenz, H.-J., & Heinemann, V. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3797 · Cited by 709
André, T., de Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4238 · Cited by 683
Microsatellite alterations in serum DNA of head and neck cancer patients
Nawroz, H., Koch, W., Anker, P., Stroun, M., & Sidransky, D. (1996) · Nature Medicine · doi:10.1038/nm0996-1035 · Cited by 658
KEMENY, N., DALY, J., REICHMAN, B., GELLER, N., BOTET, J., & ODERMAN, P. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-459 · Cited by 649
Stromal contribution to the colorectal cancer transcriptome
Isella, C., Terrasi, A., Bellomo, S. E., Petti, C., Galatola, G., Muratore, A., Mellano, A., Senetta, R., Cassenti, A., Sonetto, C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3224 · Cited by 640
Rougier, P., Laplanche, A., Huguier, M., Hay, J. M., Ollivier, J. M., Escat, J., Salmon, R., Julien, M., Roullet Audy, J. C., & Gallot, D. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1112 · Cited by 570
Allen-Mersh, T. G., Earlam, S., Fordy, C., Abrams, K., & Houghton, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90750-1 · Cited by 534
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Zhang, L., Ridgway, L. D., Wetzel, M. D., Ngo, J., Yin, W., Kumar, D., Goodman, J. C., Groves, M. D., & Marchetti, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005109 · Cited by 521
miRNA in Plasma Exosome is Stable under Different Storage Conditions
Ge, Q., Zhou, Y., Lu, J., Bai, Y., Xie, X., & Lu, Z. (2014) · Molecules · doi:10.3390/molecules19021568 · Cited by 475
Mlecnik, B., Bindea, G., Kirilovsky, A., Angell, H. K., Obenauf, A. C., Tosolini, M., Church, S. E., Maby, P., Vasaturo, A., Angelova, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6352 · Cited by 472
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
Dalerba, P., Sahoo, D., Paik, S., Guo, X., Yothers, G., Song, N., Wilcox-Fogel, N., Forgó, E., Rajendran, P. S., Miranda, S. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506597 · Cited by 470
Self-citationExosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
Matsumura, T., Sugimachi, K., Iinuma, H., Takahashi, Y., Kurashige, J., Sawada, G., Ueda, M., Uchi, R., Ueo, H., Takano, Y., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.201 · Cited by 453
Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W. N., & Pass, H. I. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318299ac32 · Cited by 452
Kemeny, N. E., Niedzwiecki, D., Hollis, D. R., Lenz, H.-J., Warren, R. S., Naughton, M. J., Weeks, J. C., Sigurdson, E. R., Herndon, J. E., Zhang, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8166 · Cited by 417
Exosomal miRNAs as cancer biomarkers and therapeutic targets
Thind, A., & Wilson, C. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.31292 · Cited by 404
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Brabletz, T. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.009 · Cited by 403
Shapiro, B., Chakrabarty, M., Cohn, E. M., & Leon, S. A. (1983) · Cancer · doi:10.1002/1097-0142(19830601)51:11<2116::aid-cncr2820511127>3.0.co;2-s · Cited by 403
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Phipps, A. I., Limburg, P. J., Baron, J. A., Burnett-Hartman, A. N., Weisenberger, D. J., Laird, P. W., Sinicrope, F. A., Rosty, C., Buchanan, D. D., Potter, J. D., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.038 · Cited by 401
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
Singh, R., Pochampally, R., Watabe, K., Lu, Z., & Mo, Y.-Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-256 · Cited by 399
Eichelser, C., Stückrath, I., Müller, V., Milde-Langosch, K., Wikman, H., Pantel, K., & Schwarzenbach, H. (2014) · Oncotarget · doi:10.18632/oncotarget.2520 · Cited by 376
Ye, S.-B., Li, Z.-L., Luo, D.-H., Huang, B.-J., Chen, Y.-S., Zhang, X.-S., Cui, J., Zeng, Y.-X., & Li, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2118 · Cited by 346
Venook, A. P., Niedzwiecki, D., Innocenti, F., Fruth, B., Greene, C., O'Neil, B. H., Shaw, J. E., Atkins, J. N., Horvath, L. E., Polite, B. N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.3504 · Cited by 336
Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
Sinicrope, F. A., Shi, Q., Smyrk, T. C., Thibodeau, S. N., Dienstmann, R., Guinney, J., Bot, B. M., Tejpar, S., Delorenzi, M., Goldberg, R. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.041 · Cited by 330
Lorenz, M., Müller, H.-H., & for the German Cooperative Group on Liver Metastases (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.243 · Cited by 308
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Affara, N. I., Ruffell, B., Medler, T. R., Gunderson, A. J., Johansson, M., Bornstein, S., Bergsland, E., Steinhoff, M., Li, Y., Gong, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.026 · Cited by 304
Self-citationGoel, A., Nagasaka, T., Arnold, C. N., Inoue, T., Hamilton, C., Niedzwiecki, D., Compton, C., Mayer, R. J., Goldberg, R., Bertagnolli, M. M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.09.018 · Cited by 300
Clinical pharmacology of hepatic arterial chemotherapy.
Ensminger, W. D., & Gyves, J. W. (1983) · PubMed · Cited by 292
van Krieken, J. H. J. M., Jung, A., Kirchner, T., Carneiro, F., Seruca, R., Bosman, F. T., Quirke, P., Fléjou, J. F., Plato Hansen, T., de Hertogh, G., et al. (2008) · Virchows Archiv · doi:10.1007/s00428-008-0665-y · Cited by 289
miR-Test: A Blood Test for Lung Cancer Early Detection
Montani, F., Marzi, M. J., Dezi, F., Dama, E., Carletti, R. M., Bonizzi, G., Bertolotti, R., Bellomi, M., Rampinelli, C., Maisonneuve, P., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv063 · Cited by 278
Spindler, K.-L. G., Pallisgaard, N., Vogelius, I., & Jakobsen, A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0564 · Cited by 251
Kerr, D. J., McArdle, C. S., Ledermann, J., Taylor, I., Sherlock, D. J., Schlag, P. M., Buckels, J., Mayer, D., Cain, D., & Stephens, R. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12388-4 · Cited by 237
Powell, A. E., Anderson, E. C., Davies, P. S., Silk, A. D., Pelz, C., Impey, S., & Wong, M. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3223 · Cited by 227
Self-citationYaeger, R., Cercek, A., Chou, J. F., Sylvester, B. E., Kemeny, N. E., Hechtman, J. F., Ladanyi, M., Rosen, N., Weiser, M. R., Capanu, M., et al. (2014) · Cancer · doi:10.1002/cncr.28729 · Cited by 203
Self-citationEberlein, T. J. (2012) · Yearbook of Surgery · doi:10.1016/j.ysur.2011.09.020 · Cited by 187
Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma
Felicetti, F., De Feo, A., Coscia, C., Puglisi, R., Pedini, F., Pasquini, L., Bellenghi, M., Errico, M. C., Pagani, E., & Carè, A. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0811-2 · Cited by 180
Colorectal Cancer: Molecular Mutations and Polymorphisms
Sameer, A. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00114 · Cited by 171
El Messaoudi, S., Mouliere, F., Du Manoir, S., Bascoul-Mollevi, C., Gillet, B., Nouaille, M., Fiess, C., Crapez, E., Bibeau, F., Theillet, C., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0297 · Cited by 171
Kemeny, N. E., Chou, J. F., Capanu, M., Gewirtz, A. N., Cercek, A., Kingham, T. P., Jarnagin, W. R., Fong, Y. C., DeMatteo, R. P., Allen, P. J., et al. (2014) · Cancer · doi:10.1002/cncr.28954 · Cited by 162
Self-citationHardingham, J. E., Grover, P. K., Winter, M. A., Hewett, P. J., Price, T. J., & Thierry, B. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00149 · Cited by 151
Lugini, L., Valtieri, M., Federici, C., Cecchetti, S., Meschini, S., Condello, M., Signore, M., & Fais, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10574 · Cited by 148
miRNA Stability in Frozen Plasma Samples
Balzano, F., Deiana, M., Giudici, S. D., Oggiano, A., Baralla, A., Pasella, S., Mannu, A., Pescatori, M., Porcu, B., Fanciulli, G., et al. (2015) · Molecules · doi:10.3390/molecules201019030 · Cited by 129
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
Lustberg, M. B., Balasubramanian, P., Miller, B. L., Garcia-Villa, A., Deighan, C., Wu, Y., Carothers, S., Berger, M. J., Ramaswamy, B., Macrae, E. R., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3622 · Cited by 126
von Einem, J. C., Heinemann, V., von Weikersthal, L. F., Vehling‐Kaiser, U., Stauch, M. B., Hass, H. G., Decker, T. W., Klein, S., Held, S., Jung, A., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1678-3 · Cited by 124
Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients
Clawson, G. A., Matters, G. L., Xin, P., Kawasawa, Y. I., Du, Z., Thiboutot, D. M., Helm, K. F., Neves, R. I., & Abraham, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134320 · Cited by 104
Kemeny, N. E., Chou, J. F., Boucher, T. M., Capanu, M., DeMatteo, R. P., Jarnagin, W. R., Allen, P. J., Fong, Y. C., Cercek, A., & D'Angelica, M. I. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24189 · Cited by 95
Self-citationGao, Y., Zhu, Y., Zhang, Z., Zhang, C., Huang, X., & Yuan, Z. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0340-0 · Cited by 92
Detection of tumour DNA in serum of colorectal cancer patients
de Kok, J. B., van Solinge, W. W., Ruers, T. J. M., Roelofs, R., van Muijen, G. N. P., Willems, J., & Swinkels, D. W. (1997) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519709055283 · Cited by 74
Bruhn, N., Beinert, T., Oehm, C., Jandrig, B., Petersen, I., Xiaowei, C. H. E. N., Possinger, K., & Fleischhacker, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06594.x · Cited by 60
Zhang, B. Y., Jones, J. C., Briggler, A. M., Hubbard, J. M., Kipp, B. R., Sargent, D. J., Dixon, J. G., & Grothey, A. F. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.09.003 · Cited by 54
Cancer Exosomes as miRNA Factories
Tran, N. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.05.008 · Cited by 51
Wetzel, M. D., Ngo, J. A., Yin, W., Kumar, D., Goodman, J. C., & Marchetti, D. (2013) · Cited by 51
Rodriguez, J. A., Huerta‐Yépez, S., Law, I. K. M., Baay-Guzman, G. J., Tirado-Rodríguez, B., Hoffman, J. M., Iliopoulos, D., Hommes, D. W., Verspaget, H. W., Chang, L., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.08.001 · Cited by 50
Path Toward Prognostication and Prediction: An Evolving Matrix
Benson, A. B., & Hamilton, S. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8646 · Cited by 45
Kelly, R. J., Kemeny, N. E., & Leonard, G. D. (2005) · Clinical Colorectal Cancer · doi:10.3816/ccc.2005.n.027 · Cited by 45
Kloten, V., Rose, M., Kaspar, S., von Stillfried, S. F., Knüchel, R., & Dahl, E. (2014) · Epigenetics · doi:10.4161/epi.32089 · Cited by 41
Balachandran, V. P., Arora, A., Gönen, M., Ito, H., Turcotte, S., Shia, J., Viale, A. J., Snoeren, N., van Hooff, S. R., Rinkes, I. H. M. B., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1071 · Cited by 38
Mayall, F. G., Fairweather, S. M., Wilkins, R., Chang, B., & Nicholls, R. J. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.5.363 · Cited by 33
Clinical Significance of Circulating DNA Microsatellite Markers in Plasma of Melanoma Patients
Nakayama, T., Taback, B., Nguyen, D.-H. T., Dorcas, D. J., Morton, D. L., Fujiwara, Y., & Hoon, D. S. �. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06596.x · Cited by 26
León, L. G., Giovannetti, E., Smid, K., van Houte, B. P. P., Hanauske, A.-R., Giaccone, G., & Peters, G. J. (2011) · Current Drug Metabolism · doi:10.2174/138920011798062337 · Cited by 7
Cited by
Wang, D., Wang, X., Si, M., Yang, J., Sun, S., Wu, H., Cui, S., Qu, X., & Yu, X. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.005 · Cited by 322
Wang, C., Lan, T., Chen, Z., Wang, X., Han, Y., Yang, N., Xu, Z., Li, H., Tao, M., & Song, Y. (2023) · Journal of Food Science · doi:10.1111/1750-3841.16772 · Cited by 20
Metadata
- Authors
- Zarour, L. R., Anand, S., Billingsley, K. G., Bisson, W. H., Cercek, A., Clarke, M. F., Coussens, L. M., Gast, C. E., Geltzeiler, C. B., Hansen, L., Kelley, K. A., Lopez, C. D., Rana, S. R., Ruhl, R., Tsikitis, V. L., Vaccaro, G. M., Wong, M. H., & Mayo, S. C.
- Venue
- Cellular and Molecular Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 3
- Issue
- 2
- Pages
- 163-173
- ISSN
- 2352-345X (ISSN-L)
- OpenAlex
- W2576118052
- Cited by
- 274
- References
- 95
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.